Skip to main content

View full-text article in PMC

. 2017 Nov 27;15(2):1694–1701. doi: 10.3892/etm.2017.5568

Table III.

Inhibitory effect of ASPS in U₁₄ solid tumour-bearing mice.

		Weight (g)

Group	Dose (mg/kg) and agent	Pre-treatment	Post-treatment	Tumour weight (g)	Inhibition rate (%)
Model	0	21.82±1.76	29.65±2.05	2.89±0.64
Positive control	30 CTX	21.98±1.91	26.47±2.19^a	0.93±0.41^a	67.82
High dose	200 ASPS	22.08±1.62	29.87±2.40^b	1.65±0.46^a,b	42.91
Medium dose	100 ASPS	22.03±1.81	30.53±2.81^b	1.61±0.58^a,b	44.29
Low dose	50 ASPS	21.94±1.71	30.12±2.17	1.82±0.53^a,b	37.02

^a

P<0.01 vs. model group

^b

P<0.01 vs. positive control group. ASPS, Acanthopanax senticosus polysaccharide; CTX, cyclophosphamide.